1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MAPK8IP2 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA THRAP3 CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA KIAA2022 CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA RAD54L CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA CASP2 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA ARHGAP45 CTRPv2 pan-cancer AAC 0.23 6e-07
mRNA POLR2A CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA EZH2 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA CASC3 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA QRICH1 CTRPv2 pan-cancer AAC 0.18 7e-07
Download CSV